Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic.
about
New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication managementAssessment of student performance and perceptions of learning in a medication use evaluation projectIs There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
P2860
Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@en
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@nl
type
label
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@en
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@nl
prefLabel
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@en
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@nl
P2093
P1476
Drug use evaluation of sitagli ...... n-owned multispecialty clinic.
@en
P2093
Benjamin Gross
Chad Gentry
Jeffrey Tunney
L Brian Cross
M Shawn McFarland
P304
P356
10.18553/JMCP.2009.15.7.563
P577
2009-09-01T00:00:00Z